These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32696371)

  • 1. Binding Thermodynamics to Intrinsically Disordered Protein Domains.
    Schön A; Freire E
    Methods Mol Biol; 2020; 2141():449-462. PubMed ID: 32696371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational and structural features of HIV-1 gp120 underlying the dual receptor antagonism by cross-reactive neutralizing antibody m18.
    Gift SK; Zentner IJ; Schön A; McFadden K; Umashankara M; Rajagopal S; Contarino M; Duffy C; Courter JR; Zhang MY; Gershoni JM; Cocklin S; Dimitrov DS; Smith AB; Freire E; Chaiken IM
    Biochemistry; 2011 Apr; 50(14):2756-68. PubMed ID: 21351734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Thermodynamic Basis of the Fuzzy Interaction of an Intrinsically Disordered Protein.
    Hadži S; Mernik A; Podlipnik Č; Loris R; Lah J
    Angew Chem Int Ed Engl; 2017 Nov; 56(46):14494-14497. PubMed ID: 28914483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.
    Dey B; Del Castillo CS; Berger EA
    J Virol; 2003 Mar; 77(5):2859-65. PubMed ID: 12584309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120.
    Schön A; Madani N; Klein JC; Hubicki A; Ng D; Yang X; Smith AB; Sodroski J; Freire E
    Biochemistry; 2006 Sep; 45(36):10973-80. PubMed ID: 16953583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folding and binding pathways of BH3-only proteins are encoded within their intrinsically disordered sequence, not templated by partner proteins.
    Crabtree MD; Mendonça CATF; Bubb QR; Clarke J
    J Biol Chem; 2018 Jun; 293(25):9718-9723. PubMed ID: 29716994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring variability in the envelope glycoprotein of HIV-1 and development of cell entry inhibitors.
    Brower ET; Schön A; Freire E
    Biochemistry; 2010 Mar; 49(11):2359-67. PubMed ID: 20166763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the Structure of the HIV-1 Envelope Trimer Using Aspartate Scanning Mutagenesis.
    Das R; Datta R; Varadarajan R
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
    Sattentau QJ; Moore JP
    J Exp Med; 1991 Aug; 174(2):407-15. PubMed ID: 1713252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational propensities of intrinsically disordered proteins influence the mechanism of binding and folding.
    Arai M; Sugase K; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9614-9. PubMed ID: 26195786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding.
    Harrop HA; Coombe DR; Rider CC
    AIDS; 1994 Feb; 8(2):183-92. PubMed ID: 8043225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring and Analyzing Binding Kinetics of Coupled Folding and Binding Reactions Under Pseudo-First-Order Conditions.
    Jensen KS
    Methods Mol Biol; 2020; 2141():629-650. PubMed ID: 32696381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.
    Chakrabarti BK; Pancera M; Phogat S; O'Dell S; McKee K; Guenaga J; Robinson J; Mascola J; Wyatt RT
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):877-87. PubMed ID: 21158699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
    Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR
    J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody m18 paratope leading to dual receptor antagonism of HIV-1 gp120.
    Gift SK; McFadden K; Zentner IJ; Rajagopal S; Zhang MY; Dimitrov DS; Chaiken IM
    Biochemistry; 2011 Apr; 50(14):2769-79. PubMed ID: 21417283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.
    Zhang W; Godillot AP; Wyatt R; Sodroski J; Chaiken I
    Biochemistry; 2001 Feb; 40(6):1662-70. PubMed ID: 11327825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing coupled conformational transitions of intrinsically disordered proteins in their interactions with target proteins.
    Koh J
    Anal Biochem; 2021 Apr; 619():114126. PubMed ID: 33567297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.
    Liu L; Patel B; Ghanem MH; Bundoc V; Zheng Z; Morgan RA; Rosenberg SA; Dey B; Berger EA
    J Virol; 2015 Jul; 89(13):6685-94. PubMed ID: 25878112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.
    Sattentau QJ; Moore JP
    J Exp Med; 1995 Jul; 182(1):185-96. PubMed ID: 7540648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural mechanism of trimeric HIV-1 envelope glycoprotein activation.
    Tran EE; Borgnia MJ; Kuybeda O; Schauder DM; Bartesaghi A; Frank GA; Sapiro G; Milne JL; Subramaniam S
    PLoS Pathog; 2012; 8(7):e1002797. PubMed ID: 22807678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.